- Home
- GLUE vs SKYT Comparison
GLUE vs SKYT Comparison
Compare GLUE & SKYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLUE | SKYT |
|---|---|---|
| Founded | 2019 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GLUE | SKYT |
|---|---|---|
| Price | $22.72 | $35.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $32.00 | $26.50 |
| AVG Volume (30 Days) | ★ 1.4M | 791.2K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1842.86 |
| EPS | ★ N/A | N/A |
| Revenue | $123,672,000.00 | ★ $442,139,000.00 |
| Revenue This Year | N/A | $40.16 |
| Revenue Next Year | $2.45 | $4.52 |
| P/E Ratio | $72.42 | ★ N/A |
| Revenue Growth | ★ 63.54 | 29.18 |
| 52 Week Low | $4.12 | $8.49 |
| 52 Week High | $25.77 | $39.93 |
Technical Indicators
Market Signals| Indicator | GLUE | SKYT |
|---|---|---|
| Relative Strength Index (RSI) | 73.77 | 45.87 |
| Support Level | $17.07 | $33.42 |
| Resistance Level | $25.56 | $35.23 |
| Average True Range (ATR) | 1.38 | 1.78 |
| MACD | 0.58 | -0.35 |
| Stochastic Oscillator | 96.30 | 25.69 |
Price Performance
Historical ComparisonAbout GLUE Monte Rosa Therapeutics Inc.
Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).
About SKYT SkyWater Technology Inc.
SkyWater Technology Inc is a U.S.-based, independent, pure-play semiconductor foundry providing foundational-node manufacturing, advanced technology development, and advanced packaging services through an integrated, multi-site operating model. It operates within the United States, with fabrication and packaging facilities in Minnesota, Texas, and Florida.l. Its segments include: Legacy SkyWater: A pure-play technology foundry that offers advanced semiconductor development and manufacturing services from its fabrication facility in Bloomington, Minnesota and advanced packaging services from its Kissimmee Florida facility; and SkyWater Texas: A high-volume manufacturer that offers manufacturing services from its fabrication facility in Austin, Texas.